Report overview
Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect majority of the population primarily due to growing incidence of autoimmune diseases such as Grave?s disease and Hashimoto's thyroiditis. Moreover, iodine deficiency is a widespread problem across the globe and is measured as a prime risk factor for the increase in prevalence of thyroid disorders.
This report aims to provide a comprehensive presentation of the global market for Thyroid Gland Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thyroid Gland Disorder Treatment. This report contains market size and forecasts of Thyroid Gland Disorder Treatment in global, including the following market information:
Global Thyroid Gland Disorder Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Thyroid Gland Disorder Treatment market was valued at US$ 2233 million in 2022 and is projected to reach US$ 2657.4 million by 2029, at a CAGR of 2.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major factors that drive the growth of the market include increase in the incidence of thyroid gland disorder, rise in the number of disease awareness programs especially in the developing countries, and development of effective combination drug therapies to treat thyroid gland disorder. However, side effects of the drugs and stringent government regulations hamper the market growth. Moreover, availability of large pool of undiagnosed patients due to asymptomatic nature of thyroid disorders help open new avenues for the market growth during the forecast period.
We surveyed the Thyroid Gland Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thyroid Gland Disorder Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Thyroid Gland Disorder Treatment Market Segment Percentages, by Type, 2022 (%)
Hyperthyroidism
Hypothyroidism
Others
Global Thyroid Gland Disorder Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Thyroid Gland Disorder Treatment Market Segment Percentages, by Application, 2022 (%)
Men
Women
Global Thyroid Gland Disorder Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Thyroid Gland Disorder Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thyroid Gland Disorder Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Thyroid Gland Disorder Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
bioM?rieux
Danaher
DiaSorin
Siemens Healthineers
Outline of Major Chapters:
Chapter 1: Introduces the definition of Thyroid Gland Disorder Treatment, market overview.
Chapter 2: Global Thyroid Gland Disorder Treatment market size in revenue.
Chapter 3: Detailed analysis of Thyroid Gland Disorder Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Thyroid Gland Disorder Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
